Zobrazeno 1 - 7
of 7
pro vyhledávání: '"G R, della Cuna"'
Autor:
F, Fanfulla, P, Pedrazzoli, G A, Da Prada, C, Bruschi, E, Dacosto, A, Zambelli, G R, della Cuna, C, Rampulla
Publikováno v:
European Respiratory Journal. 15:56-61
Pulmonary complications are frequent in patients treated with high-dose chemotherapy and autologous bone marrow transplantation for breast cancer or other solid tumours. This study analyses the development of lung toxicity, changes in respiratory fun
Publikováno v:
Anticancer research. 15(3)
In malignant cells multidrug resistance (MDR) is frequently associated with the expression of a 170 KDa P-glycoprotein (P-gp) in the plasma membrane. P-gp acts as an ATP-dependent efflux pump causing a decreased intracellular accumulation of structur
Autor:
V, Rosti, P, Pedrazzoli, L, Ponchio, C, Zibera, A, Novella, C, Lucotti, G R, Della Cuna, M, Cazzola
Publikováno v:
Haematologica. 78(4)
Several clinical studies have shown that recombinant human erythropoietin (rHuEpo) can ameliorate the anemia associated with hematologic malignancies and solid tumors. On the other hand, only a few studies have been performed to investigate whether r
Publikováno v:
Anticancer research. 11(6)
The effect of Lonidamine (LND) alone or combined with the antiestrogen Tamoxifen (TAM) or Medroxyprogesterone acetate (MPA) on cell proliferation and steroid hormone receptor content of a human estrogen sensitive breast cancer cell line was investiga
Autor:
F, Iacopino, G, Sica, P, Macrì, M G, Paggi, M, Scerrati, R, Roselli, P, Marchetti, G R, Della Cuna, L, Marini
Publikováno v:
Journal of neurosurgical sciences. 34(3-4)
Recent data from phase II trials have shown that lonidamine (LND) is effective in the treatment of tumors of various histogenesis, including gliomas. In the present work, we tested the antiproliferative effect of LND on a human glioblastoma cell line
Publikováno v:
Minerva medica. 72(12)
Cellular immunity has been studied in 92 patients with solid tumors undergoing surgery, in order to evaluate immunocompetence at the time of diagnosis and to assess the prognostic value of parameters of cellular immunity. The results show that total
Publikováno v:
European journal of cancerclinical oncology. 25(12)
The effectiveness of an 8-week, 125 mg/day intravenous course of methylprednisolone sodium succinate (MPSS) for improving quality of life in patients with preterminal cancer was investigated in a double-blind, placebo-controlled, multicenter study. Q